Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520349 · ClinicalTrials.gov registry record
Lab to Real World Assessment of E-cigarette Abuse Liability and Appeal
A clinical trial, sponsored by Truth Initiative.
- Completed
- Registry status
- 80
- Enrollment target
NCT02520349: Completed study, sponsored by Truth Initiative.
NCT02520349 is a clinical trial that has completed, run by Truth Initiative. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02520349 has completed, sponsored by Truth Initiative.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The proposed research is a longitudinal human lab study to examine how measures of abuse liability and product appeal vary by e-cigarette device type, and how these lab assessments may predict subsequent e-cigarette and other tobacco use behavior at 1,3, and 6 months. An additional aim is to evaluate e-cigarette safety and tolerability among smokers by device type.
Primary Outcome
A phlebotomist will draw 7mL of blood via venipuncture (no catheter) before and after directed tobacco product use at Lab Visits 2-6.
Interventions
- DEVICE MarkTen and e-Go e-cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2016-05 |
| Est. Completion | 2018-08-31 |
What the finished NCT02520349 record still lists
NCT02520349 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MarkTen and e-Go e-cigarettes is the first listed.
NCT02520349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02520349 about?
NCT02520349 is a clinical study titled "Lab to Real World Assessment of E-cigarette Abuse Liability and Appeal". The proposed research is a longitudinal human lab study to examine how measures of abuse liability and product appeal vary by e-cigarette device type, and how these lab assessments may predict subsequent e-cigarette and other tobacco use behavior at 1,3, and 6 months. An additional aim is to evaluat...
What is the current status of trial NCT02520349?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2016-05. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT02520349?
The interventions under investigation include: MarkTen and e-Go e-cigarettes (DEVICE).
Who is sponsoring clinical trial NCT02520349?
This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia